Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard Emerging Markets Stock Index Fund ETF (VWO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard Emerging Markets Stock Index Fund ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while Vanguard Emerging Markets Stock Index Fund ETF trades at $59.42. Which is the better fit depends on your goals.
| ARKG | VWO | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $61.24 |
52-Week Low | $23.09 | $49.54 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
VWO trades at $59.89, up 0.67% today, with a bullish technical signal from moving averages. The ETF offers broad emerging markets exposure with a low 0.06% expense ratio and a 2.4% dividend yield. Recent news highlights strong capital inflows into emerging markets and comparisons with peers like EEM, emphasizing VWO's cost advantage and exclusion of South Korean stocks due to index methodology.
The outlook for VWO is supported by diversification benefits and attractive valuations in emerging markets, but risks include geopolitical tensions and index composition gaps. Analyst sentiment is mixed, with performance heavily influenced by regional allocations and macroeconomic trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →
